Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mecocci

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Drugs|May 1, 1997
Cognitive enhancement therapy for Alzheimer's disease. The way forwardL Parnetti, U Senin, P Mecocci
Journal of the American Geriatrics Society|December 24, 1997
Increased oxidative damage in lymphocytes of Alzheimer's disease patientsP Mecocci, A Cherubini, U Senin
Annals of Neurology|November 1, 1994
Oxidative damage to mitochondrial DNA is increased in Alzheimer's diseaseP Mecocci, U MacGarvey, M F Beal
Stroke|April 3, 2001
Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head traumaM C Polidori, P Mecocci, B Frei
International Journal of Clinical & Laboratory Research|January 1, 1994
Pathogenetic mechanisms in vascular dementiaL Parnetti, D Mari, P Mecocci, et al.
Functional Neurology|May 1, 1997
Pharmaceutical treatment of cognitive disorders in Alzheimer's diseaseU Senin, A Cherubini, B Palumbo, et al.
Stroke|February 7, 2001
The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenariansG Zuliani, S Volpato, P Mecocci, et al.
Biological Psychiatry|September 15, 1993
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementiaP Mecocci, R Ekman, L Parnetti, et al.
Neurological Research|July 22, 2004
Antioxidants for the treatment of mild cognitive impairmentP Mecocci, E Mariani, V Cornacchiola, et al.
Biogerontology|November 16, 2001
Peripheral non-enzymatic antioxidant changes with human aging: a selective status reportM C Polidori, A Cherubini, U Senin, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Drugs|May 1, 1997
Cognitive enhancement therapy for Alzheimer's disease. The way forwardL Parnetti, U Senin, P Mecocci
Journal of the American Geriatrics Society|December 24, 1997
Increased oxidative damage in lymphocytes of Alzheimer's disease patientsP Mecocci, A Cherubini, U Senin
Annals of Neurology|November 1, 1994
Oxidative damage to mitochondrial DNA is increased in Alzheimer's diseaseP Mecocci, U MacGarvey, M F Beal
Stroke|April 3, 2001
Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head traumaM C Polidori, P Mecocci, B Frei
International Journal of Clinical & Laboratory Research|January 1, 1994
Pathogenetic mechanisms in vascular dementiaL Parnetti, D Mari, P Mecocci, et al.
Functional Neurology|May 1, 1997
Pharmaceutical treatment of cognitive disorders in Alzheimer's diseaseU Senin, A Cherubini, B Palumbo, et al.
Stroke|February 7, 2001
The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenariansG Zuliani, S Volpato, P Mecocci, et al.
Biological Psychiatry|September 15, 1993
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementiaP Mecocci, R Ekman, L Parnetti, et al.
Neurological Research|July 22, 2004
Antioxidants for the treatment of mild cognitive impairmentP Mecocci, E Mariani, V Cornacchiola, et al.
Biogerontology|November 16, 2001
Peripheral non-enzymatic antioxidant changes with human aging: a selective status reportM C Polidori, A Cherubini, U Senin, et al.
Pageof 10